 |
    |
| ||
 |
 | |||
 |
|
 | ||
 | ||||
| ||||
 |
||||
|
||||
|
|
Cytomedix actively targets chronic wounds in various care settings for The AutoloGel™ System. Under prospective payment, many facilities may elect to utilize products and services to maximize their outcomes cost effectively. In settings such as long-term acute care hospitals, the U.S. Department of Veterans Affairs, and public health services groups such as the Indian Health Services, where the treatment costs for non healing wounds are growing exponentially, AutoloGel has demonstrated amazing results. Non healing diabetic foot ulcers that can result in amputations, are major costs to the health care system. Cost-effective alternatives for non-healing wounds such as the AutoloGel™ System, can reduce the lifetime wound management costs that can be beneficial for the patient, the provider and the payor. Our customers have a world of experience to share, and we welcome all your comments. Please contact us with your AutoloGel success story! 
AutoloGel in Use |
| ||
 |
  | |||
| © 2009 Cytomedix. All Rights Reserved. | Site Map | Terms & Conditions |